全文获取类型
收费全文 | 6344篇 |
免费 | 503篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 146篇 |
妇产科学 | 133篇 |
基础医学 | 1053篇 |
口腔科学 | 58篇 |
临床医学 | 666篇 |
内科学 | 1294篇 |
皮肤病学 | 126篇 |
神经病学 | 703篇 |
特种医学 | 154篇 |
外科学 | 546篇 |
综合类 | 24篇 |
一般理论 | 3篇 |
预防医学 | 571篇 |
眼科学 | 100篇 |
药学 | 590篇 |
中国医学 | 11篇 |
肿瘤学 | 675篇 |
出版年
2023年 | 59篇 |
2022年 | 116篇 |
2021年 | 199篇 |
2020年 | 105篇 |
2019年 | 183篇 |
2018年 | 198篇 |
2017年 | 126篇 |
2016年 | 168篇 |
2015年 | 184篇 |
2014年 | 252篇 |
2013年 | 348篇 |
2012年 | 526篇 |
2011年 | 500篇 |
2010年 | 292篇 |
2009年 | 211篇 |
2008年 | 417篇 |
2007年 | 434篇 |
2006年 | 395篇 |
2005年 | 355篇 |
2004年 | 366篇 |
2003年 | 319篇 |
2002年 | 283篇 |
2001年 | 49篇 |
2000年 | 38篇 |
1999年 | 70篇 |
1998年 | 63篇 |
1997年 | 47篇 |
1996年 | 46篇 |
1995年 | 28篇 |
1994年 | 21篇 |
1993年 | 22篇 |
1992年 | 23篇 |
1991年 | 19篇 |
1990年 | 24篇 |
1989年 | 26篇 |
1988年 | 22篇 |
1987年 | 19篇 |
1986年 | 12篇 |
1985年 | 29篇 |
1984年 | 11篇 |
1983年 | 13篇 |
1982年 | 17篇 |
1981年 | 13篇 |
1980年 | 8篇 |
1979年 | 17篇 |
1978年 | 12篇 |
1973年 | 8篇 |
1969年 | 13篇 |
1965年 | 7篇 |
1963年 | 7篇 |
排序方式: 共有6870条查询结果,搜索用时 0 毫秒
101.
We describe ribo-polymerase chain reaction (PCR), a method for the preparation of chimeric RNA/DNA. The RNA/DNA chimeric nucleic acids are generated directly from genomic DNA starting templates with two locus-specific primers, three nucleotides in their deoxy form and the fourth in its ribo form, a DNA polymerase capable of incorporating ribo bases, a suitable buffer, and thermal cycling. We have applied ribo-PCR to resequence DNA by directly fragmenting the RNA/DNA chimeras with alkali and analyzing the fragments by mass spectrometry (MS). Mass fingerprint is used to identify deviations from the reference sequence. This method readily detects homozygous sequence deviations as well as heterozygous positions directly from genomic DNA samples. With the high-throughput capability of MS, this facile method is well suited for screening DNA sequences of limited regions of the genome in a large number of individuals. It can also be used to sequence multiple distant genomic loci in a single reaction. This novel ribo-PCR resequencing protocol was applied to different genomic loci involving nitric oxide synthase 1 (NOS1) and H19 in 30 individuals and SLCO1B1 in 95 individuals. 相似文献
102.
Sandrine Marquet Ianina Conte Belco Poudiougou Laurent Argiro Sandrine Cabantous Hélia Dessein Florence Burté Aboubacar A. Oumar Biobele J. Brown Abdoualye Traore Nathaniel K. Afolabi Abdoulaye Barry Samuel Omokhodion Ursule Ewanda Ndoumbe Wuraola A. Shokunbi Olugbemiro Sodeinde Ogobara Doumbo Delmiro Fernandez-Reyes Alain J. Dessein 《Infection and immunity》2016,84(2):590-597
Cerebral malaria (CM) is a neurological complication of infection with Plasmodium falciparum that is partly caused by cytokine-mediated inflammation. It is not known whether interleukin-17 (IL-17) cytokines, which regulate inflammation, control the development of CM. To evaluate the involvement of IL-17 cytokines in CM, we analyzed 46 common polymorphisms in IL17A, IL17F, and IL17RA (which encodes the common receptor chain of the members of the IL-17 family) in two independent African populations. A case-control study involving 115 Nigerian children with CM and 160 controls from the community (CC) showed that IL17F reference single nucleotide polymorphism (SNP) 6913472 (rs6913472) (P = 0.004; odds ratio [OR] = 3.12), IL17F rs4715291 (P = 0.004; OR = 2.82), IL17RA rs12159217 (P = 0.01; OR = 2.27), and IL17RA rs41396547 (P = 0.026; OR = 3.15) were independently associated with CM. A replication study was performed in 240 nuclear Malian family trios (two parents with one CM child). We replicated the association for 3 SNPs, IL17F rs6913472 (P = 0.03; OR = 1.39), IL17RA rs12159217 (P = 0.01; OR = 1.52), and IL17RA rs41396547 (P = 0.04; OR = 3.50). We also found that one additional SNP, IL17RA rs41433045, in linkage disequilibrium (LD) with rs41396547, was associated with CM in both Nigeria and Mali (P = 0.002; OR = 4.12 in the combined sample). We excluded the possibility that SNPs outside IL17F and IL17RA, in strong LD with the associated SNPs, could account for the observed associations. Furthermore, the results of a functional study indicated that the aggravating GA genotype of IL17F rs6913472 was associated with lower IL-17F concentrations. Our findings show for the first time that IL17F and IL17RA polymorphisms modulate susceptibility to CM and provide evidence that IL-17F protects against CM. 相似文献
103.
Ilona Hapkova Josef Skarda Caroline Rouleau An Thys Cécile Notarnicola Maria Janikova Florence Bernex Miroslav Rypka Jean-Marie Vanderwinden Sandrine Faure Jaroslav Vesely Pascal de Santa Barbara 《Experimental and molecular pathology》2013
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the gastrointestinal tract and are often associated with KIT or PDGFRA gene mutations. GIST cells might arise from the interstitial cells of Cajal (ICCs) or from a mesenchymal precursor that is common to ICCs and smooth muscle cells (SMCs). Here, we analyzed the mRNA and protein expression of RNA-Binding Protein with Multiple Splicing-2 (RBPMS2), an early marker of gastrointestinal SMC precursors, in human GISTs (n = 23) by in situ hybridization, quantitative RT-PCR analysis and immunohistochemistry. The mean RBPMS2 mRNA level in GISTs was 42-fold higher than in control gastrointestinal samples (p < 0.001). RBPMS2 expression was not correlated with KIT and PDGFRA expression levels, but was higher in GISTs harboring KIT mutations than in tumors with wild type KIT and PDGFRA or in GISTs with PDGFRA mutations that were characterized by the lowest RBPMS2 levels. Moreover, RBPMS2 levels were 64-fold higher in GIST samples with high risk of aggressive behavior than in adult control gastrointestinal samples and 6.2-fold higher in high risk than in low risk GIST specimens. RBPMS2 protein level was high in 87% of the studied GISTs independently of their histological classification. Finally, by inhibiting the KIT signaling pathway in GIST882 cells, we show that RBPMS2 expression is independent of KIT activation. In conclusion, RBPMS2 is up-regulated in GISTs compared to normal adult gastrointestinal tissues, indicating that RBPMS2 might represent a new diagnostic marker for GISTs and a potential target for cancer therapy. 相似文献
104.
105.
Mouse yolk sac cells at the 9th day of gestation were found capable of eliciting, in vitro, a graft-versus-host response manifested in splenomegaly. Reactivity of 5 x 104 and 1 x 105 yolk sac cells was greater than that of adult spleen cells tested at the same concentrations. It seems that the immune potential of yolk sac cells at this stage of development is higher than that of the adult spleens. 相似文献
106.
Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data 下载免费PDF全文
Panagiotis Baliakas Michalis Iskas Anne Gardiner Zadie Davis Karla Plevova Florence Nguyen‐Khac Jitka Malcikova Achilles Anagnostopoulos Sharron Glide Sarah Mould Kristina Stepanovska Martin Brejcha Chrysoula Belessi Frederic Davi Sarka Pospisilova Anastasia Athanasiadou Kostas Stamatopoulos David Oscier 《American journal of hematology》2014,89(3):249-255
The significance of chromosomal translocations (CTRAs) and karyotype complexity (KC) in chronic lymphocytic leukemia (CLL) remains uncertain. To gain insight into these issues, we evaluated a series of 1001 CLL cases with reliable classic cytogenetic data obtained within 6 months from diagnosis before any treatment. Overall, 320 cases were found to carry ≥1 CTRAs. The most frequent chromosome breakpoints were 13q, followed by 14q, 18q, 17q, and 17p; notably, CTRAs involving chromosome 13q showed a wide spectrum of translocation partners. KC (≥3 aberrations) was detected in 157 cases and significantly (P < 0.005) associated with unmutated IGHV genes and aberrations of chromosome 17p. Furthermore, it was identified as an independent prognostic factor for shorter time‐to‐first‐treatment. CTRAs were assigned to two categories (i) CTRAs present in the context of KC, often with involvement of chromosome 17p aberrations, occurring mostly in CLL with unmutated IGHV genes; in such cases, we found that KC rather than the presence of CTRAs per se negatively impacts on survival; (ii) CTRAs in cases without KC, having limited if any impact on survival. On this evidence, we propose that all CTRAs in CLL are not equivalent but rather develop by different processes and are associated with distinct clonal behavior. Am. J. Hematol. 89:249–255, 2014. © 2013 Wiley Periodicals, Inc. 相似文献
107.
Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse 下载免费PDF全文
Sylvain Pilorge Sophie Rigaudeau Florence Rabian Clémentine Sarkozy Anne L. Taksin Hassan Farhat Fathia Merabet Stéphanie Ghez Victoria Raggueneau Christine Terré Isabelle Garcia Aline Renneville Claude Preudhomme Sylvie Castaigne Philippe Rousselot 《American journal of hematology》2014,89(4):399-403
Gemtuzumab ozogamicin (fGO), a humanized anti‐CD33 monoclonal antibody linked to calicheamicin in combination with intensive chemotherapy gives high response rates in adult acute myeloid leukemia (AML) patients in relapse. However, reduced intensity chemotherapy in combination with fractionated GO has not been tested in aged relapsing patients. Patients from our institution with CD33+ AML aged 55 years or more in first late relapse (≥6 months) were proposed participation in a GO compassionate use program. Induction therapy consisted in fractionated GO (fGO; 3 mg/m2, days 1, 4, 7) with standard‐dose cytarabine (200 mg/m2/day, 7 days). Patients were consolidated with two courses of GO and intermediate dose cytarabine. Twenty‐four patients (median age 68 years) received fGO with cytarabine. Median follow‐up was 42 months. The response rate was 75%, including complete remission (CR) in 16 patients and CR with incomplete platelet recovery (CRp) in two patients. Two‐year overall survival (OS) was 51% (95% CI: 28–69) and 2 years relapse‐free survival (RFS) was 51% (95%CI: 25–72). Duration of second CR (CR2) was longer than first CR (CR1) in 9 out of 18 patients. Minimal residual disease (MRD) was negative in evaluable patients in CR2, particularly in NPM1 mutated cases. Toxicity was in line with that of the same fractionated single agent GO schedule. Fractionated GO with low intensity chemotherapy produced high response rates and prolonged CR2 in aged AML patients in first late relapse. Am. J. Hematol. 89:399–403, 2014. © 2013 Wiley Periodicals, Inc. 相似文献
108.
Florence Allain Benoît Delignat-Lavaud Marie-Pierre Beaudoin Vincent Jacquemet Terry E. Robinson Louis-Eric Trudeau Anne-Noël Samaha 《Neuropsychopharmacology》2021,46(2):305
D-amphetamine maintenance therapy shows promise as a treatment for people with cocaine addiction. Preclinical studies using Long Access (LgA) cocaine self-administration procedures suggest D-amphetamine may act by preventing tolerance to cocaine’s effects at the dopamine transporter (DAT). However, Intermittent Access (IntA) cocaine self-administration better reflects human patterns of use, is especially effective in promoting addiction-relevant behaviors, and instead of tolerance, produces psychomotor, incentive, and neural sensitization. We asked, therefore, how D-amphetamine maintenance during IntA influences cocaine use and cocaine’s potency at the DAT. Male rats self-administered cocaine intermittently (5 min ON, 25 min OFF x10; 5-h/session) for 14 sessions, with or without concomitant D-amphetamine maintenance therapy during these 14 sessions (5 mg/kg/day via s.c. osmotic minipump). We then assessed responding for cocaine under a progressive ratio schedule, responding under extinction and cocaine-primed reinstatement of drug seeking. We also assessed the ability of cocaine to inhibit dopamine uptake in the nucleus accumbens core using fast scan cyclic voltammetry ex vivo. IntA cocaine self-administration produced psychomotor (locomotor) sensitization, strong motivation to take and seek cocaine, and it increased cocaine’s potency at the DAT. D-amphetamine co-administration suppressed the psychomotor sensitization produced by IntA cocaine experience. After cessation of D-amphetamine treatment, the motivation to take and seek cocaine was also reduced, and sensitization of cocaine’s actions at the DAT was reversed. Thus, treatment with D-amphetamine might reduce cocaine use by preventing sensitization-related changes in cocaine potency at the DAT, consistent with an incentive-sensitization view of addiction.Subject terms: Diagnostic markers, Reward, Behavioural methods, Addiction, Predictive markers 相似文献
109.
Enora Laas Julie Labrosse Anne-Sophie Hamy Gabriel Benchimol Diane de Croze Jean-Guillaume Feron Florence Coussy Thomas Balezeau Julien Guerin Marick Lae Jean-Yves Pierga Fabien Reyal 《British journal of cancer》2021,124(8):1421
Background To compare RCB (Residual Cancer Burden) and Neo-Bioscore in terms of prognostic performance and see if adding pathological variables improve these scores.Methods We analysed 750 female patients with invasive breast cancer (BC) treated with neoadjuvant chemotherapy (NAC) at Institut Curie between 2002 and 2012. Scores were compared in global population and by BC subtype using Akaike information criterion (AIC), C-Index (concordance index), calibration curves and after adding lymphovascular invasion (LVI) and pre-/post-NAC TILs levels.Results RCB and Neo-Bioscore were significantly associated to disease-free and overall survival in global population and for triple-negative BC. RCB had the lowest AICs in every BC subtype, corresponding to a better prognostic performance. In global population, C-Index values were poor for RCB (0.66; CI [0.61–0.71]) and fair for Neo-Bioscore (0.70; CI [0.65–0.75]). Scores were well calibrated in global population, but RCB yielded better prognostic performances in each BC subtype. Concordance between the two scores was poor. Adding LVI and TILs improved the performance of both scores.Conclusions Although RCB and Neo-Bioscore had similar prognostic performances, RCB showed better performance in BC subtypes, especially in luminal and TNBC. By generating fewer prognostic categories, RCB enables an easier use in everyday clinical practice.Subject terms: Breast cancer, Breast cancer, Chemotherapy 相似文献
110.